Taro Okamoto

532 total citations
32 papers, 438 citations indexed

About

Taro Okamoto is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Taro Okamoto has authored 32 papers receiving a total of 438 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Taro Okamoto's work include Diabetes Treatment and Management (11 papers), Metabolism, Diabetes, and Cancer (6 papers) and Diabetes Management and Research (5 papers). Taro Okamoto is often cited by papers focused on Diabetes Treatment and Management (11 papers), Metabolism, Diabetes, and Cancer (6 papers) and Diabetes Management and Research (5 papers). Taro Okamoto collaborates with scholars based in Japan, United States and Australia. Taro Okamoto's co-authors include Kotoba Okuyama, Juan Camilo Arjona Ferreira, Akihiro Ito, Tadaaki Taniguchi, Yasuhiko Iwamoto, John M. Amatruda, Kenji Nonaka, Tadateru Takahashi, Kunio Tsurugi and Stephen J. Edmondston and has published in prestigious journals such as FEBS Letters, Food and Chemical Toxicology and The Journal of Arthroplasty.

In The Last Decade

Taro Okamoto

31 papers receiving 429 citations

Peers

Countries citing papers authored by Taro Okamoto

Since Specialization

Citations

This map shows the geographic impact of Taro Okamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taro Okamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taro Okamoto more than expected).

Fields of papers citing papers by Taro Okamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taro Okamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taro Okamoto. The network helps show where Taro Okamoto may publish in the future.

Co-authorship network of co-authors of Taro Okamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Taro Okamoto. A scholar is included among the top collaborators of Taro Okamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taro Okamoto. Taro Okamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A randomized, placebo‐controlled trial to assess the efficacy and safety of sitagliptin in J apanese patients with type 2 diabetes and inadequate glycaemic control on ipragliflozin 2021 ·Diabetes Obesity and Metabolism ·Yutaka Seino, Kohei Kaku, Takashi Kadowaki, Taro Okamoto, Asako Sato, (unknown), Edward A. O’Neill, Samuel S. Engel, Keith D. Kaufman	3
2	A randomized, placebo‐controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control 2021 ·Diabetes Obesity and Metabolism ·Takashi Kadowaki, Yutaka Seino, Kohei Kaku, Taro Okamoto, (unknown), Asako Sato, (unknown), Nobuyuki Oshima, Ira Gantz, Edward A. O’Neill, Samuel S. Engel, (unknown)	4
3	Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes and inadequate glycaemic control on sitagliptin 2021 ·Diabetes Obesity and Metabolism ·Kohei Kaku, Takashi Kadowaki, Yutaka Seino, Taro Okamoto, (unknown), Asako Sato, Edward A. O’Neill, Samuel S. Engel, Keith D. Kaufman	4
4	Pharmacological action and clinical results of Omarigliptin (MARIZEV<sup>®</sup> tablet), a novel dipeptidyl peptidase-4 inhibitor for once-weekly treatment of Type 2 diabetes 2017 ·Folia Pharmacologica Japonica ·Yuka Ito, Masahiko Mori, Yuki Matsumoto, Taro Okamoto	6
5	A Randomized, Placebo-Controlled Trial Evaluating the Safety and Efficacy of Adding Omarigliptin to Antihyperglycemic Therapies in Japanese Patients with Type 2 Diabetes and Inadequate Glycemic Control 2017 ·Diabetes Therapy ·(unknown), Ira Gantz, Taro Okamoto, Yuka Ito, Asako Sato, Kotoba Okuyama, Edward A. O’Neill, Samuel S. Engel, Eseng Lai	5
6	Association between SLCO1B1 rs4149056 and tegafur-uracil-induced hepatic dysfunction in breast cancer 2017 ·The Breast ·(unknown), Takako Kamio, (unknown), (unknown), Emiko Noguchi, (unknown), (unknown), Hitoshi Kanno, Kazutaka Saito, Taro Okamoto	0
7	Day-of-Surgery Mobilization Reduces the Length of Stay After Elective Hip Arthroplasty 2016 ·The Journal of Arthroplasty ·Taro Okamoto, (unknown), Stephen J. Edmondston, (unknown), (unknown), Piers Yates	55
8	Sitagliptin added to voglibose monotherapy improves glycemic control in patients with type 2 diabetes 2013 ·Journal of Diabetes Investigation ·Naoko Tajima, Takashi Kadowaki, Taro Okamoto, Asako Sato, Kotoba Okuyama, (unknown), Juan Camilo Arjona Ferreira	21
9	Valproic acid induces apoptosis dependent of Yca1p at concentrations that mildly affect the proliferation of yeast 2005 ·FEBS Letters ·Kazuhiro Mitsui, Daichi Nakagawa, Masahiro Nakamura, Taro Okamoto, Kunio Tsurugi	44
10	INHIBITORY EFFECT OF TRANSIENT ADMINISTRATION OF FLUTAMIDE (SCH-13521, 4'-NITRO-3'-TRIFLUOROMETHYLISOBUTYRANILIDE) ON DIETHYL-NITROSAMINE (DEN) INDUCED LIVER-TUMORS IN MALE B6C3F1 MICE 1995 ·Oncology Reports ·(unknown), Taro Okamoto, Yukio Ando, Hirohisa Watanabe, Akihiro Ito	1
11	Post Irradiation Examination of High Burnup PWR Fuel. 1994 ·Journal of Nuclear Science and Technology ·(unknown), (unknown), Taro Okamoto, (unknown)	3
12	Lack of Any Positive Effect of Intestinal Metaplasia on Induction of Gastric Tumors in Wistar Rats Treated with N‐Methyl‐N‐nitrosourea in Their Drinking Water 1994 ·Japanese Journal of Cancer Research ·Hiromitsu Watanabe, Yukio Ando, Kazumasa Yamada, Taro Okamoto, Akihiro Ito	14
13	Tumorigenicity study of phloxine (FR 104) in B6C3F1 mice 1994 ·Food and Chemical Toxicology ·Akihiro Ito, Nariaki Fujimoto, Taro Okamoto, Yukio Ando, Hisako Watanabe	6
14	Inhibition of Mammary Tumors by Pretreatment with 17β‐Estradiol in F344 Rats Induced with N‐Methyl‐N‐nitrosourea 1994 ·Japanese Journal of Cancer Research ·Akihiro Ito, Taro Okamoto, Nariaki Fujimoto, (unknown), Hiromitsu Watanabe	3
15	Influence of Gastric pH Modifiers on Development of Intestinal Metaplasia Induced by X‐Irradiation in Rats 1993 ·Japanese Journal of Cancer Research ·Hiromitsu Watanabe, Taro Okamoto, Yasuhiro Fudaba, (unknown), Akihiro Ito	13
16	Effects of sex hormones on induction of intestinal metaplasia by X‐irradiation in rats. 1993 ·Acta Pathologica Japonica ·Hiromitsu Watanabe, Taro Okamoto, Masahiro Matsuda, Tadateru Takahashi, (unknown), Akihiro Ito	5
17	Effects of Dose Rate and Energy Level on Fission Neutron(252Cf) Tumorigenesis in B6C3F1 Mice. 1993 ·Journal of Radiation Research ·Hiromitsu Watanabe, Taro Okamoto, Kazumasa Yamada, Yukio Ando, Akihiro Ito, Masaharu Hoshi, Shozo Sawada	1
18	Effects of Sodium Chloride and Ethanol on Stomach Tumorigenesis in ACI Rats Treated with N‐Methyl‐N′‐nitro‐N‐nitrosoguanidine: A Quantitative Morphometric Approach 1992 ·Japanese Journal of Cancer Research ·Hiromitsu Watanabe, Tadateru Takahashi, Taro Okamoto, (unknown), Akihiro Ito	20
19	Significance of Strain and Sex Differences in the Development of ²⁵²Cf Neutron‐induced Liver Tumors in Mice 1992 ·Japanese Journal of Cancer Research ·Akihiro Ito, Tadateru Takahashi, Hiromitsu Watanabe, (unknown), Taro Okamoto	11
20	The Effects of Sodium Chloride, Miso or Ethanol on Development of Intestinal Metaplasia after X‐Irradiation of the Rat Glandular Stomach 1992 ·Japanese Journal of Cancer Research ·Hiromitsu Watanabe, Taro Okamoto, Tadateru Takahashi, (unknown), Akihiro Ito	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact